The advent of CRISPR/Cas9 has revolutionized
the Genome Editing Industry.
This technique is allowing a previously unattainable
level of genomic targeting with greater efficiency
and simplicity.
Due to this ability, the share of CRISPR/Cas9
is continuously increasing in the Genome Editing
Industry.
According to the "Global CRISPR/Cas9 Market
Outlook 2022" report provided by Research
and Markets, it is anticipated that the global
CRISPR/Cas9 market will cross US $1.5 Billion
by 2022.
The growth of the market is likely to be driven
by expanding drug discovery applications and
increasing research related activities for
exploring CRISPR/Cas9 therapeutic applications.
The report, Global CRISPR/Cas9 Market Outlook
2022, provides an insight into the current
and future prospective of this market.
This report covers the major opportunities
in this area, and drivers that have impact
on the market.
The report also discusses some of the challenges
currently faced by the market.
The major application areas of CRISPR/Cas9
include cell line engineering, genetic engineering,
CRISPR plasmid development, human stem cells,
gene library development and producing GM
organisms or crops.
Cell Line Engineering is the largest area
of application of CRISPR/Cas9, followed by
Genetic Engineering.
This large share can be attributed to extensibility
and multiplexity of CRISPR/Cas9 in modifying
the multiple sites within the mammalian genome.
The genetic engineering market employing CRISPR/Cas9
is expected to witness the highest growth
in 2016-2022.
This growth is likely to be driven by reduction
of evolutionary time in comparison to previous
gene editing tools
